Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD Market Closed
Market Cap: 47.8m AUD

Relative Value

PAL price has not been updated for more than 5 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of PAL.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PAL Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
2.8
Median 5Y
2.8
Industry
4
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
32.4
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
19.9
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.5
Industry
28.1
vs History
vs Industry
Median 3Y
2.4
Median 5Y
2.4
Industry
2.8
vs History
vs Industry
Median 3Y
2.8
Median 5Y
2.8
Industry
3.9
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-7.5
Industry
8.9
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
19.3
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
24.7
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
20.5
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
28.1
vs History
vs Industry
Median 3Y
1.3
Median 5Y
1.3
Industry
2.3

Multiples Across Competitors

PAL Competitors Multiples
Palla Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Palla Pharma Ltd
ASX:PAL
47.8m AUD 2.8 -0.8 -2 -2
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 398.3 4 718.5 1 450.3 3 062.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
216.3B USD 4.9 32.9 23.5 30.4
US
Danaher Corp
NYSE:DHR
159.8B USD 6.6 45.6 24.5 37
CH
Lonza Group AG
SIX:LONN
37.3B CHF 5.3 50.9 38.8 38.8
US
Agilent Technologies Inc
NYSE:A
41.3B USD 5.9 31.7 24.4 29.2
US
IQVIA Holdings Inc
NYSE:IQV
38.5B USD 2.4 30 14.5 21.8
CN
WuXi AppTec Co Ltd
SSE:603259
258.5B CNY 5.8 17.2 19.7 19.7
KR
Samsung Biologics Co Ltd
KRX:207940
73.6T KRW 14.6 57.3 32.2 45
US
Mettler-Toledo International Inc
NYSE:MTD
28.9B USD 7.3 34.6 24.9 27.7
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.8B EUR 7 78.6 27.9 45.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Palla Pharma Ltd
ASX:PAL
Average EV/EBITDA: 168.1
Negative Multiple: -2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 450.3
5%
290.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
23.5
5%
4.7
US
Danaher Corp
NYSE:DHR
24.5
5%
4.9
CH
Lonza Group AG
SIX:LONN
38.8
18%
2.2
US
Agilent Technologies Inc
NYSE:A
24.4
N/A N/A
US
IQVIA Holdings Inc
NYSE:IQV
14.5
8%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
32.2
21%
1.5
US
Mettler-Toledo International Inc
NYSE:MTD
24.9
4%
6.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.9
20%
1.4